Become a partner

Patrik Flodr

Institute of Clinical and Molecular Pathology, University Hospital Olomouc
EDUCATION
1994-2000 Faculty of Medicine and Dentistry, Masaryk University, Brno, Czech Republic, 2000 Medicinae Universae Doctor, MD
2001 Department of Pathology/Dept. of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Hnevotinska 3, 779 00 Olomouc, Czech Republic, EU, Junior resident 2001-2006, Senior resident 2006 - ongoing
2003 1st Approbation in Pathology
2006 2nd Approbation in Pathology
2008-2015 PhD study - Potential Prognostic and Predictive Factors in Particular Lymphoproliferative Disorders

INTERNSHIPS 
2007 School of Applied Sciences (prof. John Darling), Wolverhampton, UK, 2008 The Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel, 2008 School of Molecular Pathology, CRUK Institute for Cancer Studies (prof. Paul Murray) Birmingham, UK, 2009 School of Molecular Pathology, CRUK Institute for Cancer Studies (prof.Paul Murray) Birmingham, UK

MEMBERSHIP
Czech Society of Pathology - SCP CLS JEP
International Academy of Pathology - IAP
Czech Society of Hematology - CHS CLS JEP

PUBLICATIONS
Ross, A. M., Leahy, C. I., Neylon, F., Steigerova, J., Flodr, P., Navratilova, M., ... & Murray, P. G. (2023). Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma. Life, 13(2), 521. Category Quartile Q2

Skopelidou V, Hurník P, Tulinský L, Židlík V, Lenz J, Delongová P, Hornychová H, Flodr P, Jelínek T, Muroňová L, Holub D, Džubák P, Hajdúch M. A unique case of AH-dominant type nodular pulmonary amyloidosis presenting as a spontaneous pneumothorax: a case report and review of the literature. Pathol Oncol Res. 2023 Sep 22;29:1611390. doi: 10.3389/pore.2023.1611390. PMID: 37808084; PMCID: PMC10556250. Category Quartile Q2

Kuba A, Raida L, Brychtova S, Flodr P, Mrazek F, Kriegova E, Faber E, Papajik T. Cellular senescence marker p16INK4a and NFKB1 gene polymorphisms in lower gastrointestinal acute graft versus host disease. Transpl Immunol. 2023 Feb;76:101768. doi: 10.1016/j.trim.2022.101768. Epub 2022 Dec 2. PMID: 36470572. Category Quartile Q3

Slavkovský R, Stránská J, Věnsková V, Jančik S, Kotková L, Šimová J, Vojta P, Flodr P, Bartoušková M, Študentová H, Hajdúch M, Drábek J. Development and extensive analytical validation of deep amplicon sequencing for detecting KRAS and NRAS mutations in metastatic colorectal cancer samples. Neoplasma. 2022 Jan;69(1):203-215. do i: 10.4149/neo_2021_210907N1276. Epub 2021 Dec 6. PMID: 34881628. Category Quartile Q3
  • Experience with the implementation of digital pathology and vision for the future
    The ongoing digital transformation process of all health care processes including surgical pathology laboratory is becoming mainstream option. The implementation of HW and SW requirements is reflecting institutional/laboratory needs and national or local authority budget planning and relevant subventions. The executive professional team is based on IT, IQA, EQA specialists, pathologists, oncologists, biologist, radiologists, another specialists and directorship workers. The main goal is to create at least perpetual beta version of a digital workflow process with continual improvements and modular design possibility. Unfortunately nowadays more informational systems in one institution do exist with variable and usually low or no level of an integration, that is crucial point of stabile, swift and flexible part of workflow and communication in health care. An automated multi-integrative, multidisciplinary and ergonomic digital platform with e.g. IVD applications, statistical analysis tools is needed to perform stabile, low or no bias rate of digitally transformed healthcare workflow with increased diagnostic efficiency based also on EBM databases.
Páčil sa ti článok? Zdieľaj ho a povedz o ňom aj ostatným
Nastavenie súborov cookies